The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy

Annals of Surgery

Volumn 251, Issue 4, 2010, Pages 583-591

  Rudloff, Udo ^a   Brogi, Edi ^a   Reiner, Anne S ^a   Goldberg, Jessica I ^a   Brockway, Julia P ^a   Wynveen, Christine A ^a   McCormick, Beryl ^a   Patil, Sujata ^a   Van Zee, Kimberly J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN;

ADULT; ARTICLE; BREAST NECROSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; THERAPY EFFECT;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 77950865840     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b5931e     Document Type: Article

References (31)

1. Ceilley E, Jagsi R, Goldberg S, et al. The management of ductal carcinoma in situ in North America and Europe. Results of a survey. Cancer. 2004;101: 1958-1967. (Pubitemid 39425370)
2. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol. 2001;28:400-418. (Pubitemid 32762083)
3. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24:3381-3387. (Pubitemid 46638893)
4. Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet. 2003; 362:95-102. (Pubitemid 36831018)
5. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomized trial in a population offered mammography screening. Acta Oncol. 2006;45:536-543. (Pubitemid 44167203)
6. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441-452. (Pubitemid 28135585)
7. Bijker N, Peterse JL, Duchateau L, et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer. 2001; 84:539-544. (Pubitemid 32215883)
8. Cheng L, Al-Kaisi NK, Gordon NH, et al. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst. 1997;89:1356-1360. (Pubitemid 27418026)
9. Goldstein NS, Kestin L, Vicini F. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. Am J Surg Pathol. 1999;23:1340-1348. (Pubitemid 29517327)
10. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpec-tomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer. 2002;94:1917-1924. (Pubitemid 34270043)
11. Sigal-Zafrani B, Lewis JS, Clough KB, et al. Histological margin assessment for breast ductal carcinoma in situ: precision and implications. Mod Pathol. 2004;17:81-88. (Pubitemid 41656456)
12. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455-1461. (Pubitemid 29220544)
13. Darby S, McGale P, Peto R, et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ. 2003;326:256-257. (Pubitemid 36169590)
14. Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97:1404-1411.
15. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087-2106.
16. Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6:557-565. (Pubitemid 41051933)
17. Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97:419-424. (Pubitemid 40528604)
18. Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005;23:7475-7482. (Pubitemid 46291810)
19. Kaufman EL, Jacobson JS, Hershman DL, et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26:392-398.
20. MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190:521-525. (Pubitemid 41306068)
21. Rudloff U, Brogi E, Brockway JP, et al. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer. 2009;115: 1203-1214.
22. Lagios MD. Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am. 1990;70:853-871. (Pubitemid 20223174)
23. The World Health Organization histological typing of breast tumors-second edition. The World Organization. Am J Clin Pathol. 1982;78:806-816.
24. Hughes LL. Five year results of intergroup study E5194: local excision alone (without radiation treatment) for selected patients with carcinoma ductal in situ. Breast Cancer Res Treat. 2006;100(suppl 1):S15-S29.
25. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24:1031-1036. (Pubitemid 46638798)
26. Lagios MD, Page DL, Silverstein MJ. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24:3809-3811; author reply 3811-3812. (Pubitemid 46622321)
27. Macdonald HR, Silverstein MJ, Lee LA, et al. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast. Am J Surg. 2006;192:420-422. (Pubitemid 44344210)
28. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52: 256-276. (Pubitemid 35345498)
29. Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer. 2001;37:2365-2372. (Pubitemid 33097472)
30. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2005;103:1137-1146. (Pubitemid 40328083)
31. Schuetz CS, Bonin M, Clare SE, et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 2006;66:5278-5286. (Pubitemid 43844952)